|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Research and development | |||||
| General and administrative | |||||
| Total operating expenses | |||||
| Operating loss | |||||
| Interest income | |||||
| Other income (loss), net | |||||
| Gain from change in fair value of warrant liabilities | |||||
| Net loss | |||||
| Adjustment for change in fair value of warrant liabilities | |||||
| Adjusted numerator, diluted | |||||
| Shares used in computing net loss per share, diluted (in shares) | |||||
| Net loss per share, diluted (in dollars per share) | |||||
| Shares used in computing net loss per share, basic (in shares) | |||||
| Net loss per share, basic (in dollars per share) |
Loading...
